In this tumor, we also observed not only upregulation of FGF ligands (FGF19 and FGF20; 88- and 68-fold, respectively) but also a very strong upregulation of the phospholipase PLA2G4A (345-fold). The gene discussed is FGF20; the disease is neoplasm.